Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study to Evaluate the Safety and Efficacy of IZN-6N4 for the Prevention of Chemo-Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer

NCT01400620 is registered in ClinicalTrials.gov with Izun Pharma Ltd as lead sponsor.

NCT NCT01400620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01400620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study to Evaluate the Safety and Efficacy of IZN-6N4 for the Prevention of Chemo-Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer
Lead sponsor
Izun Pharma Ltd
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2012
Completion date
January 31, 2017
Enrollment
110 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

oral mucositis